Pancreatic Cancer Research

ResearcherMedical University of BiałystokActive in the last 2 years

Katarzyna Guzińska-Ustymowicz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0479-3509; OpenAlex author ID A5000020921. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. TNS1 and TNS4 play a potential role in development of pancreatic ductal adenocarcinoma but not TNS2 and TNS3. Last author DOI 10.1080/19336918.2026.2650871↗
  2. The development of pancreatic cancer is accompanied by significant changes in the immune response in genetically predisposed mice. Co-author DOI 10.3389/fonc.2025.1603293↗
  3. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and … Co-author DOI 10.7150/ijms.32751↗
  4. Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/2016/9895721↗
  5. Reduced expression of caspase-8 and cleaved caspase-3 in pancreatic ductal adenocarcinoma cells. First author DOI 10.3892/ol.2016.4125↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna Pryczynicz · 5 shared papers, 2016–2026 · strength 0.88
  2. Justyna Dorf · 2 shared papers, 2019–2026 · strength 0.48
  3. Natalia Świsłocka · 1 shared paper, 2026 · strength 0.39
  4. Agnieszka Katarzyna Swidnicka-Siergiejko · 1 shared paper, 2025 · strength 0.27
  5. Jarosław Daniluk · 1 shared paper, 2025 · strength 0.27
  6. Urszula Daniluk · 1 shared paper, 2025 · strength 0.27
  7. A Dâbrowski · 1 shared paper, 2025 · strength 0.27
  8. Katarzyna Jakubowska · 2 shared papers, 2016 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.